NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC (EIN 95-3018799)
Tax period
2015-01-01 to 2015-12-31
Filed
2016-04-04
IRS object ID
201630959349300888
Schema version
2015v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2016-04-04T15:55:00-05:00ReturnTs
Tax Period End2015-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN521855942PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1TATE & TRYONBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line12021 L STREET NWAddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20036ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2015-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN953018799EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL TUBEROUS SCLEROSIS ASSOCIATIONBusinessNameLine1Txt
Business Name Line2INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlNATIBusinessNameControlTxt
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 Roeder Road No 750AddressLine1Txt
Citysilver springCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonKARI L ROSBECKPersonNm
Person TitlePresident and CEOPersonTitleTxt
Phone3015629890PhoneNum
Signature2016-04-04SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonElizabeth HellerPreparerPersonNm
PTINP00397829PTIN
Phone2022932200PhoneNum
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2016-09-27 15:27:22ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1TUBEROUS SCLEROSIS ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerKARI L ROSBECKPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 Roeder Road No 750AddressLine1Txt
Citysilver springCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$4,204,121GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.tsalliance.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1975FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionTHE NATIONAL TUBEROUS SCLEROSIS ASSOCIATION, D/B/A TUBEROUS SCLEROSIS ALLIANCE, IS DEDICATED TO FINDING A CURE FOR TUBEROUS SCLEROSIS COMPLEX WHILE IMPROVING THE LIVES OF THOSE AFFECTED.ActivityOrMissionDesc
Voting Members Governing Body20VotingMembersGoverningBodyCnt
Voting Members Independent20VotingMembersIndependentCnt
Total Employee21TotalEmployeeCnt
Total Volunteers1638TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$3,124,386PYContributionsGrantsAmt
CY Contributions Grants$3,514,873CYContributionsGrantsAmt
PY Program Service Revenue$1,237,559PYProgramServiceRevenueAmt
CY Program Service Revenue$478,813CYProgramServiceRevenueAmt
PY Investment Income$10,654PYInvestmentIncomeAmt
CY Investment Income$13,679CYInvestmentIncomeAmt
PY Other Revenue$6,348PYOtherRevenueAmt
CY Other Revenue$1,071CYOtherRevenueAmt
PY Total Revenue$4,378,947PYTotalRevenueAmt
CY Total Revenue$4,008,436CYTotalRevenueAmt
PY Grants And Similar Paid$457,520PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$488,698CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,529,944PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,544,461CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$16,500PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$587,943CYTotalFundraisingExpenseAmt
PY Other Expenses$2,267,797PYOtherExpensesAmt
CY Other Expenses$1,877,431CYOtherExpensesAmt
PY Total Expenses$4,271,761PYTotalExpensesAmt
CY Total Expenses$3,910,590CYTotalExpensesAmt
PY Revenues Less Expenses$107,186PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$97,846CYRevenuesLessExpensesAmt
Total Assets BOY$8,933,439TotalAssetsBOYAmt
Total Assets EOY$8,707,847TotalAssetsEOYAmt
Total Liabilities BOY$312,893TotalLiabilitiesBOYAmt
Total Liabilities EOY$287,236TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$8,620,546NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$8,420,611NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE TS ALLIANCE IS DEDICATED TO FINDING A CURE FOR TUBEROUS SCLEROSIS COMPLEX WHILE IMPROVING THE LIVES OF THOSE AFFECTED.MissionDesc
Significant New Program SrvcYes (1)SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$1,706,806ExpenseAmt
Grant$486,198GrantAmt
Revenue$477,197RevenueAmt
DescResearch Program stimulates and supports basic, translational, and clinical research on the various manifestations of tuberous sclerosis complex (TSC) to further the development of clinical therapies and, ultimately, a cure for TSC. The TS Alliance has funded $18.8 million in research on TSC since 1984. Directed by Steven L. Roberds, Ph.D., Chief Scientific Officer, the TS Alliance research grants program funds research focused on TSC proposed by researchers and aligned with the research priorities of the TS Alliance. Collaborations between basic and clinical researchers are encouraged and fostered, for example, by biennial International TSC Research Conferences. Through the TS Alliance research grants program, applications can be submitted for postdoctoral fellowships, research grants, and Rothberg Courage Awards. Grants are reviewed in a three-step process: (1) all grant applications are reviewed by a committee comprised of scientists knowledgeable about the topic area for scientific merit and of adults affected by TSC for potential impact on the lives of those affected by TSC, (2) the Science and Medical Committee of the Board of Directors evaluates the grant review committee's recommendations and the relevance of the applications to the TS Alliance's funding priorities, and (3) the Board of Directors then reviews the recommendations of the Science and Medical Committee and makes final approval for funding.A total of 11 research awards were funded during 2015 for $486,198. The TS Alliance continued to support eight research grants awarded in previous years. Additionally, three new research awards were funded beginning in 2015 to: (1) Dr. Brendan Manning (Harvard School of Public Health) to study the repurposing of inhibitors of purine synthesis for TSC treatment, (2) Dr. Polina Kosillo (University of California, Berkeley) for a postdoctoral fellowship to study the impact of TSC1 gene deletion on dopamine neurons, and (3) Dr. Mustafa Sahin (Boston Children's Hospital) to study the "hedgehog" gene and ciliary signaling in TSC. Implemented in 2006, the TSC Natural History Database captures clinical data to document the impact of the disease on a person's health over his or her lifetime. As of December 2015, 1,849 people with tuberous sclerosis complex were enrolled in the project from among 18 U.S.-based sites. The TS Alliance provides funding to participating clinics to perform data entry, monitors the integrity of the database, and makes data available to investigators to answer specific research questions and identify potential participants for clinical trials and studies. In 2015, the TS Alliance invested $467,608 in the TSC Database and designed a sub-project on epilepsy to address detailed questions about epilepsy in TSC. A contract with Novartis executed in November 2012 continued to provide TS Alliance with funding to enhance and grow the TSC Database through 2015. The TSC Biosample Repository is a TS Alliance-directed project initiated in 2014 that will impact research over the next ten years or more. High-quality biosamples such as blood, DNA, and tissues linked to detailed clinical data are required for researchers to understand why TSC is so different from person to person. Such samples are currently unavailable, and the TS Alliance's Science and Medical Committee identified this as a gap that can only be filled effectively with leadership of the TS Alliance, guided by a steering committee of clinicians and researchers. The TS Alliance contracted with the Van Andel Research Institute in Grand Rapids, Michigan, to host and distribute biosamples. Samples in the repository will be available to qualified researchers worldwide and will be associated with detailed clinical data, such as that found in our existing TSC Natural History Database. The Biosample Repository also houses samples collected as part of the TSC Clinical Research Consortium's Rare Disease Clinical Research Network project that launched in 2015. The TS Alliance launched a new TSC Preclinical Consortium in 2015, which will enable prioritization of candidate drugs or compounds based on comparing head-to-head data using consistent animal models and rigorous testing procedures. The TS Alliance is ideally positioned to drive this collaboration-with input from academic, regulatory, and industry stakeholders-by maintaining constant focus on the needs of people with TSC. To drive this project, the TS Alliance contracted with Dr. Daniela Brunner, who has more than 20 years of experience validating in vivo experimental protocols and testing drugs in many animal models of developmental, psychiatric, and neurodegenerative diseases. The TS Alliance has negotiated a license with Brigham and Women's Hospital to use specific mice developed at that institution for experiments done by the TSC Preclinical Consortium. The TS Alliance is also finalizing agreements for use of other TSC mouse models from other institutions and has solicited proposals for breeding of mice and performing epilepsy-related experiments. These proposals will be reviewed to select laboratories best suited for conducting breeding and experiments. Several small and large pharmaceutical companies have expressed interest in the consortium, and all mouse license agreements include the rights for the TS Alliance to perform experiments under contract for commercial entities.The TS Alliance continued to be a key part of the TSC Clinical Research Consortium although only a small amount of TS Alliance financial support was required because of the consortium's success in obtaining NIH funding. The five clinics comprising this consortium received NIH grants to conduct two clinical studies initiated in 2013. These two clinical studies will (1) determine what early signs or tests can identify infants with TSC at highest risk of developing autism by age three, and (2) measure the ability of EEG and brain imaging to assess the risk of newly diagnosed infants with TSC to develop infantile spasms. The biomarkers resulting from studies will have a major impact on our ability to intervene very early to prevent some of the most devastating manifestations of TSC. An interim analysis of the EEG study demonstrated that, indeed, specific abnormal EEG findings can predict that an infant will progress to develop clinical seizures. Additionally, the coordinated work to execute both of these studies has developed infrastructure and processes to form the basis of an ongoing and growing TSC Clinical Research Network. The TS Alliance continued supporting Dr. Mustafa Sahin (Boston Children's Hospital) and his research of imaging analysis in the rare diseases clinical research network. The consortium submitted an additional NIH grant application that, if funded, will add two additional clinical sites and enable the first clinical trial to prevent the development of epilepsy in infants diagnosed with TSC. As the TSC Preclinical Consortium and translational research in TSC produces additional ideas for clinical studies, the efficient initiation and conduct of future clinical trials will benefit from having this infrastructure in place to enable investigators to quickly and affordably execute studies. The TS Alliance's Chief Scientific Officer is on the leadership team of the consortium. The TS Alliance co-sponsored with the Tuberous Sclerosis Association in the UK the 2015 International TSC Research Conference: From Treatment to Prevention, held in Windsor, UK. Approximately 260 attendees from 30 countries participated in the conference featuring oral presentations, a poster session, and ancillary meetings including TSC International and TSCure, a working group of clinical researchers tackling issues necessary to plan clinical trials of very early treatments to prevent manifestations of TSC and LAM. This conference was supported by a grant from Novartis, while The Rothberg Institute for Childhood Diseases was a presenting sponsor. Support was also provided by the Brian O'Brien Family, GW Pharmaceuticals, Bcureful, the Castle Hotel Windsor, the National Institutes of Health, the National Institute of Neurological Disorders and Stroke, and the Nation Center for Advancing Translational Sciences.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$608,533ExpenseAmt
Grant$2,500GrantAmt
Revenue$1,616RevenueAmt
DescFamily Services develops programs and services that provide individuals with TSC direct access to information, resources, and specialists experienced in the diagnosis, treatment and management of TSC. The Family Services Department provided support and resources to 2,905 individuals and families dealing with TSC throughout 2015. The Vice President of Outreach attended 39 school meetings (IEPs, Evaluation Team Meetings, 504 Plan Meetings, Resolution Meetings, and Mediations) in person, through SKYPE or Facetime, and via conference calls to support families in attaining educational services for their children throughout the country. In 2015, 24 Educational Liaison volunteers worked in 24 states to connect families to free educational advocacy trainings in collaboration with the states' Parent Training and Information Centers. As a result, more than 1,885 free parent trainings/webinars on educational advocacy were offered to families dealing with educational issues for their children. In addition, the Educator Mentor Program supported 89 school systems in understanding the learning needs of children with TSC. Through a network of 35 volunteer branches of the organization, called Community Alliances, local education and support group meetings were held throughout the country. Through these Community Alliances, the TS Alliance hosted 76 educational meetings and gatherings. Among these 76 meetings was a 13-meeting Town Hall educational series. The series title was New Clinical Research in Epilepsy and Infantile Spasms. These Town Hall meetings were hosted in TSC clinics and other venues across the United States to educate TSC individuals and families about new research in epilepsy and infantile spasms with 160 people attending. One new Community Alliance, the TS Alliance of Kentucky/West Virginia, was added in 2015. The TS Alliance facilitated 7,413 peer-to-peer supports from Adult Regional Coordinators, Clinic Ambassadors, Dependent Adult Transition Resource Coordinators and through Community Alliance meetings.In 2015, the TS Alliance hosted three Regional TSC Conferences held in St. Paul, MN; Stanford, CA; and Winston-Salem, NC with 180 combined attendees. These conferences brought together individuals, parents, caregivers and members of the medical community to provide the most up-to-date information so parents and adults with TSC can make informed decisions when evaluating treatment options. These one-day symposiums offered educational outreach, information on the latest treatments in TSC, research updates, and support options. They featured the region's top experts and provided attendees the opportunity to ask questions in an open panel session with these experts in a nurturing, supportive environment. Regional TSC Conferences provide much-needed forums for the growing number of people facing the daily challenges of TSC.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$364,102ExpenseAmt
DescPublic Health Education heightens awareness of TSC throughout the general public to broaden the scope of support and understanding beyond TSC individuals and their families. During 2015, the TS Alliance produced three issues of its national magazine, Perspective, which is mailed to 15,000-plus constituents as well as posted on the website. The TS Alliance's website increases awareness and provides extensive education via 1 million-plus hits monthly from an average of more than 38,000 unique visitors. The TS Alliance also relies heavily on social media to educate constituents and promote new resources and events. Its Facebook Group boasts more than 7,000 members, while its Twitter account has 1,400-plus followers. To increase public awareness, the TS Alliance introduced a new public awareness campaign called #IAMTSC. This effort includes a dedicated website at IAMTSC.org, which garnered 21,912 page views from 10,788 unique visitors through December 31. Public service announcements were also filmed and throughout 2015 played 3,807 times on TV stations across the United States, reaching a potential audience of more than 21 million. The TS Alliance once again participated in TSC Global Awareness Day on May 15, where the #IAMTSC theme was leveraged heavily on social media and in a satellite media tour, sponsored by Novartis, featuring the TS Alliance President & CEO and the #IAMTSC campaign's creator-a dad whose daughter has TSC. This media tour reached 4.8 million people. In 2015, the TS Alliance also heavily promoted Infantile Spasms Awareness by producing four new videos for parents whose children with TSC experience these types of seizures; these videos were viewed 1,879 times by December 31. The TS Alliance, in partnership with the Child Neurology Foundation, planned and executed Infantile Spasms Awareness Week, December 1-7. The TS Alliance public awareness campaign included social media, paid advertising to first line physicians and media tour. Facebook advertising to reach misdiagnosed or those seeking a diagnosis reached 31,547 people. Advertising to first line physicians included American College of Emergency Physicians (ACEP) Now Website banner ad with 5,279 impressions, ACEP online newsletter with 21,061 subscribers, and the American Academy of Pediatrics Gateway with 50,000 impressions. The Satellite media tour with 15 aired interviews (3 TV/12 radio) reached a total audience of 2,727,039 (61,023 broadcast; 2,665,966 radio).Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)

ExpenseExpenseAmtDescDesc
$126,441Government Relations focuses on educating members of Congress about TSC to further TSC research, awareness and clinical care. The annual TS Alliance March on Capitol Hill to advocate for federal funding for the Tuberous Sclerosis Complex Research Program (TSCRP) at the Department of Defense's (DoD) Congressionally Directed Medical Research Program (CDMRP) took place in early March 2015. More than 80 members of the TSC community participated, asking their senators and representatives to sign onto Dear Colleague letters in support of TSC research. In the House, 27% or 117 Democratic and Republican Representatives signed onto a bipartisan Dear Colleague letter of support from Representatives Loretta Sanchez (D-CA) and Mike Fitzpatrick (R-PA). The number of signatures secured for the Sanchez-Fitzpatrick letter greatly exceeds the numbers set in previous years. The Senate letter was sponsored by Senators Chris Murphy (D-CT) and Johnny Isakson (R-GA) and included 22 signatures. In FY2016, the TSC Research Program at the CDMRP received a $6 million appropriation, bringing the cumulative funding to $65 million since 2002 as a result of our successful grassroots efforts. Research done through this program has recently led to additional clinical trials including: determining if imatinib, a drug FDA-approved for cancer, can safely improve levels of VEGF-D, a biomarker of lymphangioleiomyomatosis (LAM), a life-threatening lung manifestation of TSC, funded in FY2013 (the most recent year for which awards have been announced); testing a combination of two drugs to treat LAM funded in FY2012; a multi-site clinical trial testing the efficacy of an experimental topical rapamycin cream to treat the disfiguring facial tumors, facial angiofibromas, caused by TSC funded in FY2010; a clinical research network was created to test potential new therapies, to validate biomarkers, and to learn the natural history of leading to a clinical trial funded in FY2012. Building upon FY2010-funded research on glutamate receptors (mGluR5), several companies are now looking at developing drugs to link cognitive impairments in TSC to autism, anxiety, and other mental disorders. The TSCRP has also funded research to develop animal models of TSC that have seizures, enabling a better understanding of the etiology of TSC. In 2013 an industry-sponsored clinical trial began to test mTOR inhibitors to treat epilepsy in individuals with TSC. None of this progress would have been possible without the critical support provided through the TSCRP.Additional Government Relations efforts included a Congressional Briefing on Capitol Hill to commemorate TSC Global Awareness Day on May 15, 2015. Congressional staff and key members of the TSC research and grassroots communities attended the event.
$40,042Professional Education expands programs to target researchers and healthcare providers caring for individuals with TSC, medical students, genetic counselors and educators to minimize the consequences of ignorance and misinformation. The TS Alliance also participated in and presented at 32 professional meetings including: The Child Neurology Society Meeting; LAMposium - The LAM Foundation Conference; Congressional Showcase with the Coalition for Imaging and Bioengineering Research (CIBR); Association of Clinical Research Professionals Conference; Interagency Collaborative To Advance Research In Epilepsy (ICARE); Clinical Trials Transformation Initiative; Rare Disease Day at NIH; The NINDS Nonprofit Forum; NORD Annual Conference on Rare Diseases and Orphan Products; DIA Rare Diseases Workshop; ExL's 2nd Rare Disease Collaboration Summit; CBI's Evidence for Value-Based Programs; Society for the Study of Behavioral Phenotypes; 2015 BIO Patient and Health Advocacy Summit; NORD Summit; Translational Neuroscience Symposium; and the American Thoracic Society. In addition, at the American Epilepsy Society (AES) annual meeting, the TS Alliance hosted an Infantile Spasms Awareness Innovation Pavilion exhibit and a TSC reception for more than 100 researchers, clinicians, and community members. The TS Alliance also participated in two Special Interest Group scientific sessions, one on TSC and another on research resources, made available by non-profit organizations advocating for rare disorders that involve epilepsy. Further, the Vice President of Outreach has ongoing collaboration with national educational networks, such as the Association for Middle Level Education (AMLE). She also collaborates with Parent Training Information Centers (PTIs) throughout the country. Providing children with appropriate education is one key to individuals having a good quality of life.
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$166,483TotalOtherProgSrvcExpenseAmt
Total Program Service Expenses$2,845,924TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent EndowmentsYes (1)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other AssetsYes (1)ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document40IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee21EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members20GoverningBodyVotingMembersCnt
Independent Voting Member20IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local ChaptersYes (1)LocalChaptersInd
Policies Reference ChaptersYes (1)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1the organizationBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 Roeder Road No 750AddressLine1Txt
Citysilver springCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (25 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeInd
LAURA LUBBERS
CHAIR5.000.00Yes (X)Yes (X)$0$0$0
DAVID FITZMAURICE
VICE CHAIR5.000.00Yes (X)Yes (X)$0$0$0
KEITH HALL
IMMEDIATE PAST CHAIR5.000.00Yes (X)Yes (X)$0$0$0
REBECCA ANHANG PRICE
SECRETARY5.000.00Yes (X)Yes (X)$0$0$0
DARREN MILES
TREASURER5.000.00Yes (X)Yes (X)$0$0$0
MARTINA BEBIN
BOARD MEMBER2.000.00Yes (X)$0$0$0
JOHN BISSLER MD
BOARD MEMBER2.000.00Yes (X)$0$0$0
Cassandra Carroll
bOARD MEMBER2.000.00Yes (X)$0$0$0
April Cooper
BOARD MEMBER2.000.00Yes (X)$0$0$0
Beth Dean
BOARD MEMBER2.000.00Yes (X)$0$0$0
RITA DIDOMENICO
BOARD MEMBER2.002.00Yes (X)$0$0$0
STEVEN GOLDSTEIN
boARD MEMBER2.001.00Yes (X)$0$0$0
Colleen Johns
BOARD MEMBER2.000.00Yes (X)$0$0$0
BRENDAN MANNING PHD
BOARD MEMBER2.000.00Yes (X)$0$0$0
THEODORE MASTROIANNI
BOARD MEMBER2.000.00Yes (X)$0$0$0
DAVID MICHAELS
BOARD MEMBER2.001.00Yes (X)$0$0$0
DEBORA MORITZ
bOARD MEMBER5.000.00Yes (X)$0$0$0
COURTNEY O'MALLEY
BOARD MEMBER2.000.00Yes (X)$0$0$0
DAVID PARKES
BOARD MEMBER2.000.00Yes (X)$0$0$0
HENRY SHAPIRO
BOARD MEMBER2.000.00Yes (X)$0$0$0
ELIZABETH THIELE MD PHD
BOARD MEMBER2.000.00Yes (X)$0$0$0
KARI L ROSBECK
PRESIDENT & CEO54.001.00Yes (X)$164,915$3,366$22,606
RICHARD A GOLLUB
CONTROLLER & CFO (FROM MAR 15)46.503.50Yes (X)$89,652$6,956$16,691
MARY JANE PERRAUT
CFO (UNTIL APR 15)49.001.00Yes (X)$63,153$1,289$5,062
STEVEN L ROBERDS
CHIEF SCIENTIFIC OFFICER45.000.00$182,854$0$25,253Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$500,574TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$11,611TotReportableCompRltdOrgAmt
Total Other Compensation$69,612TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K2IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Cavarocchi Ruscio Dennis AssociatesBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line1600 Maryland AveSW Ste 835WAddressLine1Txt
CityWashingtonCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd
FieldValueIRS element (for citing)
ServicesGovernment Relations ConsultingServicesDesc
Compensation$101,844CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
Federated Campaigns$46,963FederatedCampaignsAmt
Membership Dues$28,136MembershipDuesAmt
Fundraising$1,435,044FundraisingAmt
Related Organizations$202,000RelatedOrganizationsAmt
All Other Contributions$1,802,730AllOtherContributionsAmt
Noncash Contributions$70,958NoncashContributionsAmt
Total Contributions$3,514,873TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
CONTRACT REVENUE900099$380,405$380,405
CONFERENCE REVENUE900099$98,408$98,408
FieldValueIRS element (for citing)
Total Program Service Revenue$478,813TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$16,038TotalRevenueColumnAmt
Exclusion$16,038ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$62,425SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$64,784SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$2,359SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$2,359TotalRevenueColumnAmt
Exclusion-$2,359ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$130,568FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,435,044ContriRptFundraisingEventAmt
Fundraising Direct Expenses$130,901FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$333TotalRevenueColumnAmt
Exclusion-$333ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescOTHERDesc
Business900099BusinessCd
Total Revenue Column$1,404TotalRevenueColumnAmt
Exclusion$1,404ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$1,404OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,008,436TotalRevenueColumnAmt
Related Or Exempt Func Income$478,813RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$14,750ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$406,419TotalAmt
Program Services$406,419ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$82,279TotalAmt
Program Services$82,279ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$600,211TotalAmt
Program Services$344,247ProgramServicesAmt
Management And General$126,537ManagementAndGeneralAmt
Fundraising$129,427FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$750,769TotalAmt
Program Services$428,883ProgramServicesAmt
Management And General$159,634ManagementAndGeneralAmt
Fundraising$162,252FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$21,280TotalAmt
Program Services$12,488ProgramServicesAmt
Management And General$4,262ManagementAndGeneralAmt
Fundraising$4,530FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$77,483TotalAmt
Program Services$45,470ProgramServicesAmt
Management And General$15,521ManagementAndGeneralAmt
Fundraising$16,492FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$94,718TotalAmt
Program Services$55,584ProgramServicesAmt
Management And General$18,973ManagementAndGeneralAmt
Fundraising$20,161FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$18,992TotalAmt
Program Services$5,864ProgramServicesAmt
Management And General$13,128ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$28,862TotalAmt
Management And General$28,862ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$100,571TotalAmt
Program Services$100,571ProgramServicesAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$239,238TotalAmt
Program Services$177,886ProgramServicesAmt
Management And General$12,421ManagementAndGeneralAmt
Fundraising$48,931FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$289,138TotalAmt
Program Services$108,490ProgramServicesAmt
Management And General$84,983ManagementAndGeneralAmt
Fundraising$95,665FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$106,681TotalAmt
Program Services$25,757ProgramServicesAmt
Management And General$80,624ManagementAndGeneralAmt
Fundraising$300FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$86,687TotalAmt
Program Services$539ProgramServicesAmt
Management And General$85,808ManagementAndGeneralAmt
Fundraising$340FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$234,542TotalAmt
Program Services$197,818ProgramServicesAmt
Management And General$4,222ManagementAndGeneralAmt
Fundraising$32,502FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$191,443TotalAmt
Program Services$159,308ProgramServicesAmt
Management And General$26,972ManagementAndGeneralAmt
Fundraising$5,163FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$48,890TotalAmt
Program Services$2,777ProgramServicesAmt
Management And General$46,113ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$7,175TotalAmt
Management And General$7,175ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
naTURAL HISTORY DATABAS$467,608$467,608
CLINICAL RESEARCH NETWO$25,568$25,568
DUES, FEES & SUBSCRIPTI$24,864$1,699$21,658$1,507
OVERHEAD ALLOCATION$0$193,757-$262,499$68,742

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$7,172TotalAmt
Program Services$2,912ProgramServicesAmt
Management And General$2,329ManagementAndGeneralAmt
Fundraising$1,931FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$3,910,590TotalAmt
Program Services$2,845,924ProgramServicesAmt
Management And General$476,723ManagementAndGeneralAmt
Fundraising$587,943FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$93,520TotalAmt
Program Services$46,760ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$46,760FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$2,333,085BOYAmt
EOY$2,873,836EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$590,177BOYAmt
EOY$499,163EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$417,226BOYAmt
EOY$316,197EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$274,463BOYAmt
EOY$2,450EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$75,260BOYAmt
EOY$107,800EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$288,659LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$142,222LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$185,887BOYAmt
EOY$146,437EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$5,057,341BOYAmt
EOY$4,761,964EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$8,933,439BOYAmt
EOY$8,707,847EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$299,920BOYAmt
EOY$270,808EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$12,973BOYAmt
EOY$16,428EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$312,893BOYAmt
EOY$287,236EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$6,117,155BOYAmt
EOY$5,643,768EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$1,623,947BOYAmt
EOY$1,897,399EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$879,444BOYAmt
EOY$879,444EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$8,620,546BOYAmt
EOY$8,420,611EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$8,933,439BOYAmt
EOY$8,707,847EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$97,846ReconcilationRevenueExpnssAmt
Other Changes In Net Assets-$297,781OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,812,563CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,199,643CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,239,048CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,124,386CurrentTaxYearMinus1YearAmt
Current Tax Year$3,514,873CurrentTaxYearAmt
Total$16,890,513TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,812,563CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,199,643CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,239,048CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,124,386CurrentTaxYearMinus1YearAmt
Current Tax Year$3,514,873CurrentTaxYearAmt
Total$16,890,513TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$2,428,340SubstantialContributorsTotAmt
Public Support Total170$14,462,173PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$9,722CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$9,794CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$13,335CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$13,455CurrentTaxYearMinus1YearAmt
Current Tax Year$16,038CurrentTaxYearAmt
Total$62,344TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$13,037CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$23,048CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,984CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$9,351CurrentTaxYearMinus1YearAmt
Current Tax Year$1,401CurrentTaxYearAmt
Total$52,821TotalAmt
FieldValueIRS element (for citing)
Total Support$17,005,678TotalSupportAmt
Gross Receipts Rltd Activities$3,167,937GrossReceiptsRltdActivitiesAmt
Public Support CY1700.85040PublicSupportCY170Pct
Public Support PY1700.87500PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule A, Part II, Line 10, Explanation of Other Income:FormAndLineReferenceDesc
ExplanationINCOME FROM OTHER PROGRAM RELATED ACTIVITIES - 2011 Amount: $ 13,037. 2012 Amount: $ 23,048. 2013 Amount: $ 5,984. 2014 Amount: $ 9,351. 2015 Amount: $ 1,401.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,047FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$121,394FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$126,441FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$4,167,932FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$4,294,373FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$364,719FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$91,180FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$323,610CurrentYearMinus3Amt
Current Year Minus2$354,161CurrentYearMinus2Amt
Current Year Minus1$362,797CurrentYearMinus1Amt
Current Year$364,719CurrentYearAmt
Total$1,405,287TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$2,107,931LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$141,410CurrentYearMinus3Amt
Current Year Minus2$142,520CurrentYearMinus2Amt
Current Year Minus1$178,975CurrentYearMinus1Amt
Current Year$126,441CurrentYearAmt
Total$589,346TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$80,903CurrentYearMinus3Amt
Current Year Minus2$88,540CurrentYearMinus2Amt
Current Year Minus1$90,699CurrentYearMinus1Amt
Current Year$91,180CurrentYearAmt
Total$351,322TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$526,983GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$16,179CurrentYearMinus3Amt
Current Year Minus2$919CurrentYearMinus2Amt
Current Year Minus1$905CurrentYearMinus1Amt
Current Year$5,047CurrentYearAmt
Total$23,050TotalAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,061,299BeginningYearBalanceAmt
Contributions$29,940ContributionsAmt
Investment Earnings Or Losses-$93,294InvestmentEarningsOrLossesAmt
Other Expenditures$202,000OtherExpendituresAmt
Administrative Expenses$32,428AdministrativeExpensesAmt
End Year Balance$4,763,517EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$4,994,766BeginningYearBalanceAmt
Contributions$47,153ContributionsAmt
Investment Earnings Or Losses$179,553InvestmentEarningsOrLossesAmt
Other Expenditures$97,500OtherExpendituresAmt
Administrative Expenses$62,673AdministrativeExpensesAmt
End Year Balance$5,061,299EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$4,457,365BeginningYearBalanceAmt
Contributions$42,690ContributionsAmt
Investment Earnings Or Losses$718,381InvestmentEarningsOrLossesAmt
Other Expenditures$197,200OtherExpendituresAmt
Administrative Expenses$26,470AdministrativeExpensesAmt
End Year Balance$4,994,766EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$4,221,150BeginningYearBalanceAmt
Contributions$43,996ContributionsAmt
Investment Earnings Or Losses$420,983InvestmentEarningsOrLossesAmt
Other Expenditures$202,000OtherExpendituresAmt
Administrative Expenses$26,764AdministrativeExpensesAmt
End Year Balance$4,457,365EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$4,443,045BeginningYearBalanceAmt
Contributions$29,825ContributionsAmt
Investment Earnings Or Losses-$47,583InvestmentEarningsOrLossesAmt
Other Expenditures$175,000OtherExpendituresAmt
Administrative Expenses$29,137AdministrativeExpensesAmt
End Year Balance$4,221,150EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.81160BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.18460PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.00380TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgYes (1)EndowmentsHeldRelatedOrgInd
Related Org List Sch RYes (1)RelatedOrgListSchRInd

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$156,545OtherCostOrOtherBasisAmt
Depreciation$61,945DepreciationAmt
Book Value$94,600BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$14,829OtherCostOrOtherBasisAmt
Depreciation$12,429DepreciationAmt
Book Value$2,400BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$117,285OtherCostOrOtherBasisAmt
Depreciation$67,848DepreciationAmt
Book Value$49,437BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$146,437TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDescBook ValueBookValueAmt
INTEREST IN NET ASSETS OF AFFILIATE$4,763,518
DUE FROM AFFILIATE-$1,554
FieldValueIRS element (for citing)
Total Book Value Other Assets$4,761,964TotalBookValueOtherAssetsAmt
Total Rev Etc Audited Fincl Stmt$3,714,202TotalRevEtcAuditedFinclStmtAmt
Donated Services And Use Fclts$3,547DonatedServicesAndUseFcltsAmt
Other Revenue-$297,781OtherRevenueAmt
Revenue Not Reported-$294,234RevenueNotReportedAmt
Revenue Subtotal$4,008,436RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$4,008,436TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$3,914,137TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$3,547DonatedServicesUseFcltsAmt
Expenses Not Reported$3,547ExpensesNotReportedAmt
Expenses Subtotal$3,910,590ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$3,910,590TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Part V, Line 4:THE ALLIANCE'S ENDOWMENTS CONSIST OF Two FUNDS ESTABLISHED FOR DIFFERENT PURPOSES. THE ALLIANCE'S ENDOWMENT INCLUDE One TRADITIONAL DONOR-RESTRICTED ENDOWMENT FUNDS AND ONE BOARD-DESIGNATED ENDOWMENT FUND. THE BOARD-DESIGNATED ENDOWMENT FUND SOLELY CONSISTS OF THE ENDOWMENT FUND'S UNRESTRICTED NET ASSET BALANCE.
Part XI, Line 2d - Other Adjustments:CHANGE IN INTEREST IN AFFILIATE -297,781.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe00GRANTS TO RECIPIENTSRESEARCH AWARDS$79,779
Australia00GRANTS TO RECIPIENTSGrant to Tuberous Sclerosis Australia$2,500
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee0ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$82,279SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$82,279TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtValuation Method UsedValuationMethodUsedDesc
europeresearch grant$29,779checkcash
EUroperesearch grant$50,000CHECkCASH
FieldValueIRS element (for citing)
Total501c3 Org0Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePart I, Line 2:FormAndLineReferenceDesc
ExplanationGrantee organizations are expected to file annual progress reports to outlined grant goals and milestones. These reports are reviewed by a committee of peers. This committee makes determinations based on quality of work to goals if the grantee organization will continue to receive funding. A final written and financial report is required of all grantees.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1walksEvent1Nm
Gross Receipts Event1$1,095,551GrossReceiptsEvent1Amt
Charitable Contri Event1$993,051CharitableContriEvent1Amt
Gross Revenue Event1$102,500GrossRevenueEvent1Amt
Other Direct Expenses Event1$57,705OtherDirectExpensesEvent1Amt
Event2COMEDY FOR A CUREEvent2Nm
Gross Receipts Event2$182,813GrossReceiptsEvent2Amt
Charitable Contri Event2$169,383CharitableContriEvent2Amt
Gross Revenue Event2$13,430GrossRevenueEvent2Amt
Other Direct Expenses Event2$37,572OtherDirectExpensesEvent2Amt
Other Events Total11OtherEventsTotalCnt
Gross Receipts Other Events$287,248GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$272,610CharitableContriOtherEventsAmt
Gross Revenue Other Events$14,638GrossRevenueOtherEventsAmt
Oth Direct Expnss Other Events$35,624OthDirectExpnssOtherEventsAmt
Gross Receipts Total$1,565,612GrossReceiptsTotalAmt
Charitable Contributions Tot$1,435,044CharitableContributionsTotAmt
Gross Revenue Total Events$130,568GrossRevenueTotalEventsAmt
Oth Direct Expnss Total Events$130,901OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$130,901DirectExpenseSummaryEventsAmt
Net Income Summary-$333NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (8 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
Brigham & Women's Hospital
75 St Francis StreetBostonMA02115042312909501 (c )(3)$72,484RESEARCH GRANT
Vanderbilt University
Financial MgmtDept 1236 PO BoxDallasTX753121236620476822501 (c )(3)$49,317RESEARCH GRANT121236
Cornell University
Weil Medical Col 575 Lexington AveNew YorkNY10022131623978501 (c )(3)$42,000RESEARCH GRANT9th Fl
Yale University
Grant Contract Admin PO Box 1873New HavenCT065081873060646973501 (c )(3)$75,000RESEARCH GRANT
Harvard University School of Public Health
Pres Fellows of Harvard Col PO BoxBostonMA022415649042103580501 (c )(3)$75,000RESEARCH GRANT415649
Children's Hospital Los Angeles
4650 Sunset Blvd Mail Stop 97Los AngelesCA900275649956121916501 (c )(3)$75,000RESEARCH GRANT
Harvard T H Chan School of Public Health
Pres Fellows of Harvard Col PO BoxBostonMA022415649042103580501 (c )(3)$50,000RESEARCH GRANT415649
Boston Children's Hospital
Research Finance PO Box 414413BostonMA022414413042774441501 (c )(3)$18,750RESEARCH GRANT
FieldValueIRS element (for citing)
Total501c3 Org8Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Part I, Line 2:THE TS ALLIANCE HAS FUNDED MORE THAN $18.8 MILLION IN RESEARCH ON TSC SINCE 1984. DIRECTED BY STEVEN L. ROBERDS, PH.D, CHIEF SCIENTIFIC OFFICER, THE TS ALLIANCE RESEARCH GRANTS PROGRAM FUNDS RESEARCH FOCUSED ON TSC WITH PRIORITIES SET BY THE RESEARCHERS TOGETHER WITH THE TS ALLIANCE. COLLABORATIONS BETWEEN BASIC AND CLINICAL RESEARCHERS ARE ENCOURAGED AND FOSTERED, AND THE TS ALLIANCE IS WORKING TO INCREASE FUNDING FOR RESEARCH ON TSC. THROUGH THE TS ALLIANCE RESEARCH GRANTS PROGRAM, APPLICATIONS CAN BE SUBMITTED FOR: - POSTDOCTORAL & CLINICAL FELLOWSHIPS - TSC SUPPLEMENTAL FUNDING AWARDS - ROTHBERG COURAGE AWARD - DRUG SCREENING AWARD - CLINICAL RESEARCH NETWORK
FORM 990, SCHEDULE I, LINE 2:GRANTS ARE REVIEWED IN A THREE-STEP PROCESS: - A GRANT REVIEW COMMITTEE COMPOSED OF INDIVIDUALS KNOWLEDGEABLE ABOUT THE CLINICAL AND BASIC COMPONENTS OF TSC, REVIEW ALL GRANT APPLICATIONS FOR SCIENTIFIC MERIT, RELEVANCY TO THE FUNDING PRIORITIES OF THE ORGANIZATION AND WITH A FOCUS ON UNDERSTANDING THE MECHANISMS OF TSC AND/OR THE DEVELOPMENT OF TREATMENTS AND THERAPIES FOR THE MANIFESTATIONS OF THE DISEASE. - THE SCIENCE AND MEDICAL COMMITTEE OF THE BOARD OF DIRECTORS THEN REVIEWS THE RECOMMENDATIONS TO THE BOARD OF DIRECTORS. - THE BOARD OF DIRECTORS THEN REVIEWS THE RECOMMENDATIONS OF THE SCIENCE AND MEDICAL COMMITTEE AND MAKES FINAL APPROVAL FOR THE FUNDING OF GRANT APPLICATIONS.

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (1)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgYes (1)CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KARI L ROSBECK
PRESIDENT & CEO$153,756$3,138$11,159$228$0$0$5,117$104$22,464$458$192,496$3,928$0$0
STEVEN L ROBERDS
CHIEF SCIENTIFIC OFFICER$170,320$0$12,534$0$0$0$5,676$0$25,114$0$213,644$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Part I, Line 5KARI LUTHER ROSBECK, RICHARD GOLLUB, MARY JANE PERRAUT, AND STEVE ROBERDS ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THE COMPENSATION COMMITTEE.
Part I, Line 6KARI LUTHER ROSBECK, RICHARD GOLLUB, MARY JANE PERRAUT, AND STEVE ROBERDS ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THE COMPENSATION COMMITTEE.
FORM 990, SCHEDULE J:KARI LUTHER ROSBECK, RICHARD GOLLUB, AND MARY JANE PERRAUT ARE EMPLOYEES OF TUBEROUS SCLEROSIS ALLIANCE AND ARE COMPENSATED THROUGH TS ALLIANCE. THESE INDIVIDUALS SERVE THE ENDOWMENT WITHOUT COMPENSATION.

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution10ContributionCnt
Noncash Contributions Rpt F990$64,784NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescFOOD, BEVERAGE, AND OTHER EVENT SUPPLIESDesc
Contribution8ContributionCnt
Noncash Contributions Rpt F990$6,174NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part III, line 2The TS Alliance launched a new TSC Preclinical Consortium in 2015, which will enable prioritization of candidate treatments based on comparing head-to-head data using consistent animal models and rigorous testing procedures.
Form 990, Part VI, Section A, line 6Membership is available to any person who subscribes to the purposes and objectives of the corporation, without regard to race, religion, gender, sexual orientation, age, color, national origin or mental or physical handicap or disability. There shall be no limit to the number of members in the Corporation. 1) There may be one or more classes of membership as determined by the Board. 2) Membership is not transferable or assignable.
Form 990, Part VI, Section A, line 7aThe TS Alliance is a membership-based organization, which means members help elect the Board of Directors. The TS Alliance membership program in 2015 was composed of several levels from complimentary basic members to gold level at $1,000.
Form 990, Part VI, Section B, line 11THE FORM 990 IS REVIEWED, IN DETAIL, BY THE BOARD OF DIRECTORS AUDIT AND FINANCE COMMITTEES. RECOMMENDATIONS ARE MADE BY THE COMMITTEE MEMBERS FOR ANY CHANGES/EDITS/ADDITIONS. AFTER THOSE HAVE BEEN INCORPORATED BOTH COMMITTEES VOTE WHETHER TO APPROVE AND THEN FORWARD THE 990 TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE PERFORMS THE FINAL REVIEW AND THEN VOTES WHETHER TO APPROVE ON BEHALF OF THE BOARD OF DIRECTORS. A COPY OF THE APPROVED 990 IS SHARED WITH THE ENTIRE BOARD.
Form 990, Part VI, Section B, line 12cAnnually each member of the board of directors will receive notice of the organization's conflict of interest statement. Each member will be provided with a statement to make disclosure of any potential conflict of interest. If during the course of the year a potential conflict of interest arises that has not previously been disclosed, the board members will make written notice of a potential conflict of interest and recuse himself or herself from any discussions and votes in connection with the issue identified. Any time a member is recused from discussion on an issue, the minutes of committee meeting and board meeting will duly record such actions. The following potential conflicts of interest were disclosed for 2015: BOARD MEMBER BRENDAN MANNING, PH.D., IS EMPLOYED AT HARVARD COLLEGE, WHICH RECEIVED A $50,000 ROTHBERG COURAGE AWARD GRANT TO STUDY THE REPURPOSING OF CLINICALLY APPROVED IMMUNOSUPPRESSANTS AS A SAFE AND EFFECTIVE TREATMENT FOR TSC. BOARD MEMBER ELIZABETH THIELE, M.D., PH.D., IS EMPLOYED AT MASSACHUSETTS GENERAL HOSPITAL, WHICH RECEIVED $33,700 FOR HER WORK ON THE TSC NATURAL HISTORY DATABASE.
Form 990, Part VI, Section B, line 15The Compensation Committee reviews and approves the salaries of the President/CEO, Chief Scientific Officer, Controller & CFO, and any employee appearing on the Form 990, in accordance with the Tuberous Sclerosis Alliance Bylaws. Such review and approval occurs initially upon hiring, upon annual reviews and whenever modified. The Organization's executive remuneration has been structured to ensure that it: is reasonable; provides a competitive compensation program to retain, attract and reward key employees and achieves clear alignment between total remuneration and delivered business and personal performance over the short and long-terms. The compensation is reviewed by the Compensation Committee to ensure: - Comparability, - Proper review, and - Substantiation in setting the compensation.
Form 990, Part VI, Section C, line 19All governing documents, conflict of interest policy and financial statements are available upon written request.
Part IXIn 2015, the TS Alliance invested time and funds in the search for a new Controller and CFO. The board felt it was vital to make this investment for the continuity and success of organizational infrastructure. We also experienced the unplanned, sudden death of the Director of Special Events and Corporate Partnerships, leading to a nationwide search for a replacement. Simultaneously, the TS Alliance was building new research tools, the Biosample Repository and the Preclinical Consortium. Although the foundation of a very strong program was built for exponential growth in 2016, the Biosample Repository did not collect samples as quickly as planned and the Preclinical Consortium did not enter the testing phase that was anticipated in 2015. As a result of all of these circumstances, the expense ratios for administration and fundraising are heavier than planned at 27% and program expenses lower than planned at 73%.
Form 990, Part XI, line 9:change in interest in affiliate -297,781.
FORM 990, PART XII, LINE 2CTHE AUDIT REVIEW PROCESS HAS REMAINED UNCHANGED FROM THE PRIOR YEAR.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1TUBEROUS SCLEROSIS ALLIANCE ENDOWMENT FUNDBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1801 ROEDER ROAD 750AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
EIN521926919EIN
Primary ActivitiesTO RECEIVE GIFTS THAT WILL BE INVESTED TO GENERATE INCOME FOR TSAPrimaryActivitiesTxt
Legal Domicile StateMDLegalDomicileStateCd
Exempt Code Section501(c)(3)ExemptCodeSectionTxt
Public Charity StatusLine 11b, IIPublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1National tuberous sclerosis association (TSA)BusinessNameLine1Txt
FieldValueIRS element (for citing)
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp

Other Organization Name OtherOrganizationName

FieldValueIRS element (for citing)
Business Name Line1tuberous sclerosis alliance endowment fundBusinessNameLine1Txt
FieldValueIRS element (for citing)
Transaction TypeCTransactionTypeTxt
Involved$202,000InvolvedAmt
Method Of Amount DeterminationcashMethodOfAmountDeterminationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.